Healthcare sector | Health Information Services industry
| Price | $33.09 |
|---|---|
| Shares Outstanding | 45.44M |
| All-Time Low | $1.29 |
| 52-Week Low | $22.66 |
| Net Cash / Share | $0 |
|---|---|
| Net Current Assets / Share | $-1.38 |
| Net Tangible Assets / Share | $5.93 |
| Shares Outstanding Ave Change (Annual) | 1.64% |
| Shares Δ YoY | 1.85% |
| Avg CA Burn (Annual %) | 2.02% (as of 3-8-2026) |
| Avg CA Burn (Quarterly %) | -3.81% (as of 3-8-2026) |
| Max Earning Power / Share | $4.65 |
|---|---|
| Adjusted Earning Power |
$-0.42
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
1.39%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 105.5M (as of 3-8-2026) |
| Avg EBITDA (5Q) | 25.3M (as of 3-8-2026) |
| Avg Net Income (5Y) | 18.9M (as of 3-8-2026) |
| Avg Net Income (5Q) | 3.6M (as of 3-8-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 3-8-2026 |
| Consecutive Years Paid | No | 3-8-2026 |
| Pays Dividend | No | 3-8-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | Yes | 3-8-2026 |
| Net Income Positive | No | 3-8-2026 |
| Current Dividend Streak | No | 3-8-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $5.99 | 269.6M ($269,566,000) | 45M (45,027,000) |
| 2025-09-30 | Quarterly | $5.69 | 255.3M ($255,266,000) | 44.9M (44,876,000) |
| 2025-06-30 | Quarterly | $6.28 | 291.6M ($291,553,000) | 46.4M (46,419,000) |
| 2025-03-31 | Quarterly | $6.00 | 281.1M ($281,057,000) | 46.8M (46,843,604) |
| 2024-12-31 | Quarterly | $5.65 | 261.9M ($261,884,000) | 46.4M (46,382,000) |
| 2024-12-31 | Annual | $5.65 | 261.9M ($261,884,000) | 46.4M (46,382,000) |
| 2024-09-30 | Quarterly | $5.20 | 240.6M ($240,633,000) | 46.3M (46,313,000) |
| 2023-12-31 | Annual | $3.85 | 175.3M ($175,312,000) | 45.5M (45,539,000) |
| 2022-12-31 | Annual | $1.61 | 72.2M ($72,197,000) | 44.7M (44,747,000) |
| 2021-12-31 | Annual | $0.75 | 33.2M ($33,178,000) | 44.2M (44,179,000) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 1.1B ($1,112,238,000) |
| 2023-12-31 | 1.1B ($1,147,112,000) |
| 2022-12-31 | 1.3B ($1,295,947,000) |
| 2021-12-31 | 1.1B ($1,132,018,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-03-06 | 45,435,918 | +559,396 |
| 2025-11-07 | 44,876,522 | -1,057,729 |
| 2025-09-17 | 45,934,251 | -49 |
| 2025-08-08 | 45,934,300 | -909,300 |
Latest short-interest change: 2,670,305 shares (8.54% of float) | Days to cover: 3.14
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-12 | 2,670,305 shares | +140,377 | +5.55% |
| 2026-02-27 | 2,529,928 shares | +270,651 | +11.98% |
| 2026-02-11 | 2,259,277 shares | -421,020 | -15.71% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital; and specialized automated dispensing systems for hospitals, health systems, and post-acute care facilities. It also provides central pharmacy dispensing services; IV compounding services; turnkey solution designed to help health systems establish, manage, and optimize an entity-owned specialty pharmacy, as well as support onsite management of specialty pharmacy services, including payer contracting, staffing, licensing, and 340B program administration. In addition, the company offers inventory optimization services comprising predictive and prescriptive analytics, benchmarking, workflow tools, and clinical resources, as well as medication inventory visibility; patient engagement, clinical, and financial solutions; medication adherence solutions, which include single-dose automation solutions, automated and semi-automated filling equipment, various medication blister card packaging and packaging supplies; and software that guides users through the manual filling process. Further, it provides professional services, such as technology installation, program management, customer education and training, change management services, and related offerings; technical services comprising post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; and retail pharmacy and hospital automation outside the United States business. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. The company was incorporated in 1992 and is headquartered in Fort Worth, Texas.